Relationship between primary eradication of Helicobacter pylori and drinking habits in women: collaborative research between a pharmacy and a clinic

Kayoko Ozeki, Michio Asano, Takahisa Furuta, Toshiyuki Ojima, Kayoko Ozeki, Michio Asano, Takahisa Furuta, Toshiyuki Ojima

Abstract

Helicobacter pylori is a cause of stomach cancer and peptic ulcer. For prevention, improving the eradication rate of H. pylori is crucial. However, the association between eradication and lifestyle of infected patients, including alcohol consumption, remains unclear. We explored associations between failed primary eradication therapy and drinking status by sex. This study involved 356 patients who visited a pharmacy with prescriptions for primary H. pylori eradication therapy. We assessed drinking habits using a questionnaire. Data on patients with failed primary eradication were provided by the nearby local clinic. We performed logistic regression analysis to examine the effect of drinking habit and frequency of drinking on failed primary eradication by sex. The odds ratio of primary eradication failure in female patients with a drinking habit was 3.75 (P = 0.001), but that in male patients was not significant. The odds ratio tended to increase in relation to drinking frequency in women. Frequent consumption of alcohol is not only likely to affect eradication, but also has a large impact on the bodies of women, who are more susceptible than men to the effects of alcohol. Thus, women should take greater care in alcohol consumption.

Keywords: Drinking habits; Helicobacter pylori; first-line eradication; women.

Conflict of interest statement

Kayoko Ozeki, Michio Asano, Takahisa Furuta and Toshiyuki Ojima declare that they have no conflicts of interest.

References

    1. World Health Organization (1997) The role of the pharmacist in the health care system. Preparing the future pharmacist: Curricular development. Report of a third WHO consultative group on the role of the pharmacist. World Health Organization (). Accessed 17 May 2018.
    1. World Health Organization (2006) New tool to enhance role of pharmacists in health care. World Health Organization (). Accessed 17 May 2018.
    1. Kiel PJ and McCord AD (2005) Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Annals of Pharmacotherapy 39, 1828–1832.
    1. Avery AJ et al. (2012) A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. Lancet 379, 1310–1319.
    1. Japan Pharmaceutical Association (2013) Pharmacist vision. Japan Pharmaceutical Association (). Accessed 17 May 2018.
    1. Watanabe T et al. (1998) Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 115, 642–648.
    1. Eurogast Study Group (1993) An international association between Helicobacter pylori infection and gastric cancer. Lancet 341, 1359–1363.
    1. Uemura N et al. (2001) Helicobacter pylori infection and the development of gastric cancer. The New England Journal of Medicine 345, 784–789.
    1. Forman D et al. (1991) Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. British Medical Journal 302, 1302–1305.
    1. Leung WK et al. (2004) Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut 53, 1244–1249.
    1. Asaka M et al. (2003) Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Journal of Gastroenterology 38, 339–347.
    1. Fuccio L et al. (2009) Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Annals of Internal Medicine 151, 121–128.
    1. Sakaki H et al. (2013) Ten-year trend of the cumulative Helicobacter pylori eradication rate for the ‘Japanese eradication strategy’. Digestion 88, 272–278.
    1. Sasaki M et al. (2010) Changes in 12-year first-line eradication rate of Helicobacter pylori based on triple therapy with proton pump inhibitor, amoxicillin and clarithromycin. Journal of Clinical Biochemistry and Nutrition 47, 53–58.
    1. Sue S et al. (2017) The superiority of vonoprazan-based first-line triple therapy with clarithromycin: a prospective multi-center cohort study on Helicobacter pylori eradication. Internal Medicine 56, 1277–1285.
    1. Cutler AF and Schubert TT (1993) Patient factors affecting Helicobacter pylori eradication with triple therapy. American Journal of Gastroenterology 88, 505–509.
    1. Broutet N et al. (2003) Risk factors for failure of Helicobacter pylori therapy – results of an individual data analysis of 2751 patients. Alimentary Pharmacology and Therapeutics 17, 99–109.
    1. Namiot D et al. (2008) Smoking and drinking habits are important predictors of Helicobacter pylori eradication. Advances in Medical Sciences 53, 310–315.
    1. Ozeki K et al. (2016) Association of hay fever with the failure of Helicobacter pylori primary eradication. Internal Medicine 55, 1729–1734.
    1. Brenner H et al. (1977) Relation of smoking and alcohol and coffee consumption to active Helicobacter pylori infection: cross sectional study. British Medical Journal 315, 1489–1492.
    1. Liu SY et al. (2016) Alcohol intake and Helicobacter pylori infection: a dose–response meta-analysis of observational studies. Infectious Diseases 48, 303–309.
    1. Hirschowitz BI et al. (1956) The action of ethyl alcohol on gastric acid secretion. Gastroenterology 30, 244–256.
    1. Lenz HJ, Ferrari-Taylor J and Isenberg JI (1983) Wine and five percent ethanol are potent stimulants of gastric acid secretion in humans. Gastroenterology 85, 1082–1087.
    1. Demol P et al. (1985) Different actions of intravenous ethanol on basal (=interdigestive) secretion of gastric acid, pancreatic enzymes and bile acids and gastrointestinal motility in man. Alcohol and Alcoholism 20, 19–26.
    1. Singer MV et al. (1987) Action of ethanol and some alcoholic beverages on gastric acid secretion and release of gastrin in humans. Gastroenterology 93, 1247–1254.
    1. Arne TE and Sven ES (1997) Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic. U.S. patent 5629305. 13 May 1997.
    1. Moayyedi P, Chalmers DM and Axon AT (1997) Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori. Journal of Gastroenterology 32, 24–27.
    1. Waxman DJ and Holloway MG (2009) Sex differences in the expression of hepatic drug metabolizing enzymes. Molecular Pharmacology 76, 215–228.
    1. Li J et al. (2015) Sex-dependent regulation of hepatic CYP3A by growth hormone: roles of HNF6, C/EBPα, and RXRα. Biochemical Pharmacology 93, 92–103.
    1. Yang L et al. (2012) Sex differences in the expression of drug-metabolizing and transporter genes in human liver. Journal of Drug Metabolism and Toxicology 3(3). doi: 10.4172/2157-7609.1000119.
    1. Wolbold R et al. (2003) Sex is a major determinant of CYP3A4 expression in human liver. Hepatology 38, 978–988.
    1. Austin KL et al. (1980) Intersubject and dose-related variability after intravenous administration of erythromycin. British Journal of Clinical Pharmacology 10, 273–279.
    1. Feierman DE, Melinkov Z and Nanji AA (2003) Induction of CYP3A by ethanol in multiple in vitro and in vivo models. Alcoholism Clinical and Experimental Research 27, 981–988.
    1. Drik T et al. (2013) In-vitro evaluation of chronic alcohol effects on expression of drug-metabolizing and drug-transporting proteins. Journal of Pharmacy and Pharmacology 65, 1518–1525.
    1. Furuta T et al. (2005) Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for Helicobacter pylori infection. Clinical Gastroenterology and Hepatology 3, 564–573.
    1. Eriksson CJ et al. (1996) Estrogen-related acetaldehyde elevation in women during alcohol intoxication. Alcoholism Clinical and Experimental Research 20, 1192–1195.
    1. Baraona E et al. (2001) Gender differences in pharmacokinetics of alcohol. Alcoholism Clinical and Experimental Research 25, 502–507.
    1. Ley CJ, Lees B and Stevenson JC (1992) Sex-and menopause-associated changes in body-fat distribution. American Journal of Clinical Nutrition 55, 950–954.
    1. Cederbaum AI (2012) Alcohol metabolism. Clinics in Liver Disease 16, 667–685.
    1. Haro C et al. (2016) Intestinal microbiota is influenced by gender and body mass index. PLoS ONE 11, e0154090.
    1. Baena JM et al. (2002) Relation between alcohol consumption and the success of Helicobacter pylori eradication therapy using omeprazole, clarithromycin and amoxicillin for 1 week. European Journal of Gastroenterology and Hepatology 14, 291–296.
    1. Emanuele MA, Wezeman F and Emanuele NV (2002) Alcohol's effects on female reproductive function. Alcohol Research and Health 26, 274–281.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren